Robert W Nickells

8PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - proteins and peptides (incl. medical proteomics)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 26, 2023
BAX activation in mouse retinal ganglion cells occurs in two temporally and mechanistically distinct steps.

Margaret E Maes, Ryan J Donahue, Cassandra L Schlamp

|Jun 09, 2023
BAX activation in mouse retinal ganglion cells occurs in two temporally and mechanistically distinct steps.

Margaret E Maes, Ryan J Donahue, Cassandra L Schlamp

|Jul 22, 2022
BclXL (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury.

Olivia J Marola, Sarah E R Yablonski, Peter G Shrager

|Aug 11, 2021
BCLXL gene therapy moderates neuropathology in the DBA/2J mouse model of inherited glaucoma.

Ryan J Donahue, Rachel L Fehrman, Jenna R Gustafson

|May 23, 2021
The effects of a mitochondrial targeted peptide (elamipretide/SS31) on BAX recruitment and activation during apoptosis.

Joshua A Grosser, Rachel L Fehrman, Dennis Keefe

|Jan 11, 2021
Characteristics of intracellular propagation of mitochondrial BAX recruitment during apoptosis.

Joshua A Grosser, Margaret E Maes, Robert W Nickells

Pageof 2